Implications of a Breast Cancer Screening Programme for a Community Before introducing a breast cancer screening service into a population, several important questions need to be answered so that we can foresee its implications and realistically balance the benefits likely to be achieved against the hazards it may entail and against the resources needed to implement it.
It is often assumed that the success or value of screening programmes can be measured simply in terms of the number of cases of disease which they detectas though having reached the point of diagnosis all is plain sailing, cure automatically follows and there are no undesirable side-effects. But experience in screening for other diseases has revealed the naivety of this assumption, and now a number of criteria for weighing up the pros and cons of this form of preventive medicine have been developed (Wilson & Jungner 1968) .
In assessing the total impact of a breast cancer screening programme on a community we need to have information on four interlinked points:
(1) The acceptability of screening to the women concerned.
(2) The validity and safety of the tests to be used. (3) The effect of early treatment on the natural history of the disease. (4) The resources which will be required. This paper reviews some of the evidence so far available on these points, taken mainly from the large study by Shapiro et al. in New York (1973) , but partly also from the early results of the West London screening study. Table 1 shows the proportion of women in New York who accepted the screening invitation initially and who then attended for annual reexamination. There is a small drop-out with each successive attendance. If annual screening were extended over many years, there would probably be some women who would miss a few examinations and then turn up again later, but there is, as yet, no information on this point; at a guess, a screening service would be fortunate if it achieved ongoing screening of as much as 50 % of the whole population of women in the relevant age group. Fortunately, however, the women who attend regularly are likely to include most of those at high risk of the disease.
Acceptability ofScreening

Validity ofTests
The second point concerns the tests to be used. It seems fairly clear that at present a combination of clinical examination and mammography is likely to give the biggest yield. Table 2 shows the rate of cancer detection by these screening methods in both the New York and the West London studies, compared with an estimate of the annual incidence in the absence of a screening programme. In the case of the New York study, this latter figure is the annual incidence in the control group of women who were not offered screening; in the case of West London, the estimate of incidence is based on national cancer registration data. As expected, the initial prevalence at first screening is higher than the subsequent annual incidence from repeated screening. The prevalence in West London is remarkably high; apart from some 200 women who were invited to be screened because they were known to have a positive family history, there has been no deliberate attempt to offer the service selectively to high risk women and we are looking into possible explanations of this very high yield.
These figures refer to cancers detected by a combination of clinical examination and mammography, but it is, of course, also important to know whether both tests are necessary, and whether cases would fail to be detected if one test were omitted. In New York it was found that 33% of cancers would have been missed if mammography were not used, and 45% missed if there had been no clinical examination, with, rather surprisingly, only 22% detected by both methods (Table 3) . The corresponding figures in West London, which may be more typical of current mammography techniques, are 38 % detected by mammography alone, 43 % detected by both methods and 19 % by clinical examination
alone. An indication that the cancers detected by screening are at an early stage is given by the proportion of them with no histological evidence of nodal involvement (70 %). The number of cancers detected in the West London study is still too small to put any great reliance on the proportions with no nodal involvement detected by each method but the results seem to be in g%neral agreement with the New York findings.
There may, of course, also be some cancers which are not detected by either methodfalse negatives to the combined screening procedure. The extent of these can only be determined from cancers that present symptomatically before the next screening is due, and it can never be proved if these were present at the time of screening and were missed, or whether they arose de novo in the interval. In New York, with annual rescreening, 47 cancers were found within one year of a negative screening test; this represents 25% of the cancers occurring in that group of women in that year. In an attempt to measure this factor more accurately and to determine the optimum interval between successive screenings, in West London we are rescreening at sixmonthly intervals. Information from rescreening is still incomplete but we have, unfortunately, had one case of advanced cancer presenting symptomatically four months after a negative test, and we have detected two cancers at the sixmonthly check.
A further point related to the likelihood of missing cancers is the variation between different observers in their interpretation of the findings in the same woman. In West London the findings obtained by two independent clinical examinations of the breasts, and two independent interpretations of the mammograms are being compared. Looking at the agreement on the need to refer cases subsequently found to be malignant to a surgeon, the clinicians were agreed in 7 of the 13 cases referred on clinical grounds (54 %), whereas the radiologists were agreed in 12 of the 17 cases referred on X-ray evidence (70 %). The implications of this are that the variability, particularly in interpreting clinical examinations, is likely to lead in practice to a considerable false negative rate.
It is also important to estimate the false positive rate from the screening test because this represents one of the unfortunate consequences of screening which must be minimized. In this context, false positives are those women who, on the basis of the screening tests, are referred for surgical opinion but who do not turn out to have cancer. The word 'false' is a misnomer since many of these women are-correctly found by screening to have benign breast disease for which they are referred. Nevertheless, this factor must count in the disadvantages of screening, by virtue of the needless worry caused to these women before they are finally reassured, the inconvenience and morbidity caused to those who have to have a biopsy, and the extra load placed on surgical and pathology resources. In the New York study, less than 1 % of the screening tests resulted in a biopsy for benign disease, which could be regarded as an acceptable level, but in West London this aspect is more worrying with the biopsy rate running at about 7%. This lends weight to the suggestion that the population of women who come to be screened in the West London study contain a high proportion who are likely to have breast disease.
Section ofRadiology
Safety ofradiation dose received in mammography: The possibility of actually inducing breast cancers by repeated mammography is a real one. Information comes both from Hiroshima survivors (Jablon & Kato 1972) and from several series of follow-up studies done on women whose tuberculosis was treated by artificial pneumothorax and who were exposed to repeated fluoroscopy during this treatment (Myrden & Hiltz 1969 , MacKenzie 1965 , Cook et al. 1974 . Both these groups ofwomen have had an increased incidence of breast cancer 15-20 years after irradiation. It seems, however, that the risk falls off markedly in women over the age of 35 at the time of irradiation, possibly due to decreased tissue radiosensitivity with increasing age. The radiation dose obtained with the mammography techniques as used in New York was about 8 rads per examination, and at these levels in young women the possibility of inducing breast cancers cannot be ignored. These doses have now been greatly reduced and while we cannot be absolutely sure that no cancer will ever be induced, we feel reasonably confident that provided screening by mammography is limited to women over 40 and the radiation dose is kept to the lowest level compatible with good films, the benefit resulting is likely to be much greater than the harm.
Effect ofEarly Treatment on Natural History ofDisease Turning now to the question of benefit, the only evidence again comes from the New York study. Table 4 shows that five years from the date of entry to the study, there was a substantial reduction in mortality from breast cancer in the women who were offered screening compared with those who were not. The study population includes those who did not respond as well as those who were screened and this therefore represents the impact which a screening programme would have on a whole population. The reduction in deaths occurred principally among women in their 50s, and screening apparently had no beneficial effect under this age. Table 5 shows the proportion of women with breast cancer who were dead within five years, broken down according to the method of detection. From this it can be seen that the improved mortality in the study group resulted almost entirely from the cancers which were detected at screening. If looked at in even more detail, the cases detected by mammography alone had a case fatality rate of only 2%, and those by clinical examination alone, a rate of 22 %.
These results show the benefit achieved by annual screening of middle-aged women over a four-year period. Attempting to predict from this the reduction in mortality by extending the programme over anything up to a thirty-year period (aiming to screen women between the ages of 40 and 70) is a difficult task. Some useful work on this aspect is being done by Knox (1975) who has developed a computerized simulation of breast cancer screening programmes based largely on evidence from the New York study. He uses this to extrapolate the effect of offering screening over a longer time period, and also to predict the likely effect of varying the frequency of screening by the different methods in different risk categories of women. His conclusions suggest that mortality might be reduced by up to 1300 deaths each year in this countrya very worthwhile target albeit a relatively small decrease in the total mortality from breast cancer which is about 11 000 deaths per year.
Resources
But what is such a programme going to cost in terms of manpower and money? It is important to recognize that the costs of screening include not merely the cost of performing the tests (about £5 per examination) but also the costs of all the follow-up procedures (including biopsies) needed to sort out the true cancers from all those women with positive tests. The costs to the woman herself must be considered as well as the costs to the health service. The manpower question is even more serious than the direct financial costs, for there are at present not nearly enough people with the requisite skills available. This is particularly true of radiologists and radiographers. Apart from the scientific questions, particularly on benefit, which are only partly resolved, any implementation of screening on a national scale would be quite impossible unless preceded by training programmes for the staff to do it. In summary, the implications of a breast cancer screening programme offered to a population of middle-aged women are that it could have a limited but nevertheless valuable effect in reducing mortality and morbidity from breast cancer; limited because inevitably some people will not take advantage of the screening programme, because the tests will fail to detect some cases, and because available treatments even applied at an early stage of the disease cannot guarantee to cure all cancers. Further investigation is still required of the extent of long-term benefit which could be achieved by screening strategies which are feasible within health service resources, but there are certainly grounds for optimism that screening may at last make some inroad into the misery caused by this disease.
Surgical Aspects of Breast Cancer Screening It seems clear that a programme of screening for the early detection of cancer of the breast can reduce significantly the mortality from the disease. Together with the other centres established by the Department of Health and Social Security our task in Manchester is to assess the feasibility of providing such a programme on a national scale, and, in order to achieve this, we have attempted to answer four vital questions.
(1) Is it safe? This question refers to the possible dangers from radiation associated with repeated mammographic examinations and is dealt with in detail by Asbury & Barker (1975).
(2) Can it be done by non-medical staff? It is inconceivable that with our present resources of medical manpower we could provide regular clinical and radiographic examinations for the several million women at risk. In the North West we are particularly short of radiologists and there is sometimes difficulty in maintaining the routine service. In South Manchester we have recruited and trained a team of nurses to carry out the clinical examination, and of radiographers to read the X-rays. Patients are examined independently by a nurse and a surgeon and each records the findings independently on separate standard documents. In a similar way each mammogram is read and recorded separately by a radiographer and a consultant radiologist. In this way it is possible to compare the diagnostic accuracies of nurses and surgeons, radiographers and radiologists, and of the joint medical team with the non-medical team.
(3) Do women want it? The articulate minority who demand this service might not be representative of the community as a whole and previous studies in Britain have suggested that the response to an invitation for screening might be quite small. In Manchester the response and attitudes of women in our community are being monitored carefully by the Department of Social Research.
(4) Can the hospitals cope with the additional work? It is generally accepted that virtually all lumps in the breast should be removed, which makes it necessary to carry out a relatively large number of biopsies to find relatively few cancers. This implies additional work for the surgical service, the length of whose waiting lists already gives cause for concern. Before a screening service can be established it is essential to provide an estimate of this additional workload.
Patients Studied
All women over the age of 50 in two large group practices in South Manchester were invited by letter to attend for a screening examination. Those who failed to respond received a second invitation. Up to June 1974 June , 1873 women had responded to the invitation and had been examined clinically and radiologically at the Breast Clinic of the University Hospital of South Manchester. When questioned carefully many women (545) admitted to symptoms of some kind in relation to their breasts and in 20 (4%) of these patients lesions were found which required biopsy. Of the 1328 women who were free from symptoms 28 (2 %) were found to have lesions which required biopsy. Of the 48 biopsies taken 10 revealed cancer of the breast, 7 in women with symptoms and 3 in women who were unaware of any abnormality.
In order to provide an adequate experience for the nurses and radiographers, patients referred to hospital in the normal way because of symptoms in relation to their breasts were examined at the screening clinic. Of 788 patients referred for this reason 331 required a biopsy and 61 were found to have cancer. The total experience available to the trainees was thus 2661
